Hepatitis B vaccination and undifferentiated connective tissue disease: Another brick in the wall of the Autoimmune/Inflammatory Syndrome Induced by Adjuvants (ASIA)

Journal of Clinical Rheumatology

Volumn 19, Issue 5, 2013, Pages 231-233

  Perricone, Carlo ^a   Shoenfeld, Yehuda ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE;

ADJUVANT DISEASE; AUTOIMMUNE INFLAMMATORY SYNDROME INDUCED BY ADJUVANT; AUTOIMMUNITY; AUTOINFLAMMATORY DISEASE; CLINICAL FEATURE; CONNECTIVE TISSUE DISEASE; HEPATITIS B; HUMAN; IMMUNE RESPONSE; MOLECULAR MIMICRY; MORBIDITY; MORTALITY; PHYSICAL DISEASE BY BODY FUNCTION; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE; VACCINATION;

CONNECTIVE TISSUE DISEASES; FEMALE; HEPATITIS B VACCINES; HUMANS;

EID: 84881457860     PISSN: 10761608     EISSN: 15367355     Source Type: Journal    
DOI: 10.1097/RHU.0b013e31829d56f1     Document Type: Review

References (22)

1. Doria A, Mosca M, Gambari PF, et al. Defining unclassifiable connective tissue diseases: incomplete, undifferentiated, or both? J Rheumatol. 2005;32:213-215.
2. Mosca M, Tani C, Talarico R, et al. Undifferentiated connective tissue diseases (UCTD): simplified systemic autoimmune diseases. Autoimmun Rev. 2011;10:256-258.
3. Bruzzese V, Zullo A, Hassan C. Connective tissue disease following hepatitis B vaccination. J Clin Rheumatol. 2013;19:280-281.
4. Shoenfeld Y, Agmon-Levin N. 'ASIA'Vautoimmune/inflammatory syndrome induced by adjuvants. J Autoimmun. 2011;36:4-8.
5. Amital H, Eric Gershwin M, Shoenfeld Y. Reshaping the mosaic of autoimmunity. Semin Arthritis Rheum. 2006;35:341-343.
6. Bodolay E, Csiki Z, Szekanecz Z, et al. Five-year follow-up of 665 Hungarian patients with undifferentiated connective tissue disease (UCTD). Clin Exp Rheumatol. 2003;21:313-320.
7. Aron-Maor A, Shoenfeld Y. Vaccination and systemic lupus erythematosus: the bidirectional dilemmas. Lupus. 2001;10:237-240.
8. Cohen AD, Shoenfeld Y. Vaccine-induced autoimmunity. J Autoimmun. 1996;9:699-703.
9. Perricone C, Agmon-Levin N, Valesini G, et al. Vaccination in patients with chronic or autoimmune rheumatic diseases: the ego, the id and the superego. Joint Bone Spine. 2012;79:1-3.
10. Cruz-Tapias P, Blank M, Anaya JM, et al. Infections and vaccines in the etiology of antiphospholipid syndrome. Curr Opin Rheumatol. 2012;24:389-393.
11. Molina V, Shoenfeld Y. Infection, vaccines and other environmental triggers of autoimmunity. Autoimmunity. 2005;38:235-245.
12. HogenEsch H. Mechanisms of stimulation of the immune response by aluminum adjuvants. Vaccine. 2002;31:S34-S39.
13. McMahon BJ, Helminiak C,Wainwright RB, et al. Frequency of adverse reactions to hepatitis B vaccine in 43,618 persons. Am J Med 1992;92:254-257.
14. Rinaldi M, Perricone R, Blank M, et al. AntiYSaccharomyces cerevisiae autoantibodies in autoimmune diseases: from bread baking to autoimmunity. Clin Rev Allergy Immunol. 2013. [Epub ahead of print].
15. Cereda V, Vergati M, Huen NY, et al. Maturation of human dendritic cells with Saccharomyces cerevisiae (yeast) reduces the number and function of regulatory T cells and enhances the ratio of antigen-specific effectors to regulatory T cells. Vaccine. 2011;29:4992-4999.
16. Zold E, Szodoray P, Nakken B, et al. Alfacalcidol treatment restores derailed immune-regulation in patients with undifferentiated connective tissue disease. Autoimmun Rev. 2011;10:155-162.
17. Roh S, Kim K. Overcoming tolerance in hepatitis B virus transgenic mice: a possible involvement of regulatory T cells. Microbiol Immunol. 2003;47:453-460.
18. Li JC, Tan DM, Liu HB, et al. The roles of CD4+CD25+ T regulatory cells and Foxp3 mRNA expression in the subjects with and without responses to hepatitis B virus vaccination. Zhonghua Gan Zang Bing Za Zhi. 2010;18:726-730.
19. Tovey MG, Lallemand C. Adjuvant activity of cytokines. Methods Mol Biol. 2010;626:287-309.
20. Perricone C, Agmon-Levin N, Colafrancesco S, et al. Vitamin and systemic lupus erythematosus: to D or not to D. Expert Rev Clin Immunol. 2013;9:397-399.
21. Szodoray P, Nakken B, Barath S, et al. Progressive divergent shifts in natural and induced T-regulatory cells signify the transition from undifferentiated to definitive connective tissue disease. Int Immunol. 2008;20:971-979.
22. Borchers AT, Keen CL, Shoenfeld Y, et al. Vaccines, viruses, and voodoo. J Investig Allergol Clin Immunol. 2002;12:155-168.